167 related articles for article (PubMed ID: 35393463)
21. Specific sites of metastases in invasive lobular carcinoma: a retrospective cohort study of metastatic breast cancer.
Inoue M; Nakagomi H; Nakada H; Furuya K; Ikegame K; Watanabe H; Omata M; Oyama T
Breast Cancer; 2017 Sep; 24(5):667-672. PubMed ID: 28108967
[TBL] [Abstract][Full Text] [Related]
22. Long-term statin use and risk of ductal and lobular breast cancer among women 55 to 74 years of age.
McDougall JA; Malone KE; Daling JR; Cushing-Haugen KL; Porter PL; Li CI
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1529-37. PubMed ID: 23833125
[TBL] [Abstract][Full Text] [Related]
23. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
[TBL] [Abstract][Full Text] [Related]
24. Differential patterns of allelic loss in estrogen receptor-positive infiltrating lobular and ductal breast cancer.
Loo LW; Ton C; Wang YW; Grove DI; Bouzek H; Vartanian N; Lin MG; Yuan X; Lawton TL; Daling JR; Malone KE; Li CI; Hsu L; Porter PL
Genes Chromosomes Cancer; 2008 Dec; 47(12):1049-66. PubMed ID: 18720524
[TBL] [Abstract][Full Text] [Related]
25. Differences in sensitivity to neoadjuvant chemotherapy among invasive lobular and ductal carcinoma of the breast and implications on surgery-A systematic review and meta-analysis.
O'Connor DJ; Davey MG; Barkley LR; Kerin MJ
Breast; 2022 Feb; 61():1-10. PubMed ID: 34864494
[TBL] [Abstract][Full Text] [Related]
26. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
27. Comparison of sentinel lymph node biopsy between invasive lobular carcinoma and invasive ductal carcinoma.
Adachi Y; Sawaki M; Hattori M; Yoshimura A; Gondo N; Kotani H; Iwase M; Kataoka A; Onishi S; Sugino K; Terada M; Horisawa N; Mori M; Oze I; Iwata H
Breast Cancer; 2018 Sep; 25(5):560-565. PubMed ID: 29536376
[TBL] [Abstract][Full Text] [Related]
28. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers.
Bharat A; Gao F; Margenthaler JA
Am J Surg; 2009 Oct; 198(4):516-9. PubMed ID: 19800459
[TBL] [Abstract][Full Text] [Related]
29. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004.
Eheman CR; Shaw KM; Ryerson AB; Miller JW; Ajani UA; White MC
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1763-9. PubMed ID: 19454615
[TBL] [Abstract][Full Text] [Related]
30. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights.
Da Ros L; Moretti A; Querzoli P; Pedriali M; Lupini L; Bassi C; Carcoforo P; Negrini M; Frassoldati A
Clin Breast Cancer; 2018 Oct; 18(5):e1133-e1139. PubMed ID: 29759595
[TBL] [Abstract][Full Text] [Related]
31. Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas.
Li CI; Malone KE; Porter PL; Lawton TJ; Voigt LF; Cushing-Haugen KL; Lin MG; Yuan X; Daling JR
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):43-50. PubMed ID: 18199710
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: a case control study.
Lee JH; Park S; Park HS; Park BW
World J Surg Oncol; 2010 Apr; 8():34. PubMed ID: 20423478
[TBL] [Abstract][Full Text] [Related]
33. [Preoperative MRT of the breast in invasive lobular carcinoma in comparison with invasive ductal carcinoma].
Diekmann F; Diekmann S; Beljavskaja M; Bick U; Taupitz M; Blohmer JU; Winzer KJ; Hamm B
Rofo; 2004 Apr; 176(4):544-9. PubMed ID: 15088179
[TBL] [Abstract][Full Text] [Related]
34. Is there an association between invasive lobular carcinoma of the breast and a family history of gastric cancer?
Chikman B; Davidson T; Kais H; Jeroukhimov I; Leshno A; Sandbank J; Halevy A; Lavy R
Fam Cancer; 2016 Jan; 15(1):41-7. PubMed ID: 26358115
[TBL] [Abstract][Full Text] [Related]
35. Survival analysis in patients with invasive lobular cancer and invasive ductal cancer according to hormone receptor expression status in the Korean population.
Kwon D; Ko BK; Jung SP; Kim HK; Kim EK; Jung YS; Youn HJ; Lee SB
PLoS One; 2022; 17(1):e0262709. PubMed ID: 35051228
[TBL] [Abstract][Full Text] [Related]
36. The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology.
Rakha EA; Gill MS; El-Sayed ME; Khan MM; Hodi Z; Blamey RW; Evans AJ; Lee AH; Ellis IO
Breast Cancer Res Treat; 2009 Mar; 114(2):243-50. PubMed ID: 18404368
[TBL] [Abstract][Full Text] [Related]
37. Mixed invasive ductal and lobular carcinoma has distinct clinical features and predicts worse prognosis when stratified by estrogen receptor status.
Xiao Y; Ma D; Ruan M; Zhao S; Liu XY; Jiang YZ; Shao ZM
Sci Rep; 2017 Sep; 7(1):10380. PubMed ID: 28871133
[TBL] [Abstract][Full Text] [Related]
38. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
Jayasinghe UW; Bilous AM; Boyages J
Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for ductal, lobular, and mixed ductal-lobular breast cancer in a screening population.
Phipps AI; Li CI; Kerlikowske K; Barlow WE; Buist DS
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1643-54. PubMed ID: 20501751
[TBL] [Abstract][Full Text] [Related]
40. Magnitude of trastuzumab benefit in patients with HER2-positive, invasive lobular breast carcinoma: results from the HERA trial.
Metzger-Filho O; Procter M; de Azambuja E; Leyland-Jones B; Gelber RD; Dowsett M; Loi S; Saini KS; Cameron D; Untch M; Smith I; Gianni L; Baselga J; Jackisch C; Bell R; Sotiriou C; Viale G; Piccart-Gebhart M
J Clin Oncol; 2013 Jun; 31(16):1954-60. PubMed ID: 23589556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]